Globus Medical Inc. Class A (GMED)
NYSE: GMEDHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
GMED stock chart
Technical analysisKey statistics
All statistics- Market cap
- $8.86B
- P/E (TTM)
- 16.48
- Forward P/E
- 12.53
- EPS (TTM)
- $4.06
- Dividend yield
- None
- 52-week range
- 66.63 – 101.40
- Day range
- 66.63 – 69.54
- Volume / Avg
- 1.51M / 1.63M
- Beta
- —
- Shares outstanding
- 110.04M
52-week range
GMED stock today
On Nov 20, GMED ended the session at $66.89, shedding $1.71 (2.49%), versus the S&P 500's 3.70% decline. Shares are 34.0% below their 52-week high of $101.40, set on Jan 8, 2026 and 0.4% above the 52-week low of $66.63, near the bottom of the past year's range. GMED is down 23.4% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 22.2%.
At 16.5x trailing earnings, Globus Medical trades below the peer-group median of 62.7x. Its forward P/E of 12.5x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About Globus Medical
Company profileGlobus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Keith W. Pfeil
- Headquarters
- Audubon, PA
- Employees
- 6,000
- IPO year
- 2012
- Website
- globusmedical.com
Financial highlights
Full financialsIn fiscal 2025, Globus Medical generated $2.94 billion in revenue, up 16.7% from fiscal 2024, its 15th consecutive year of revenue growth. Net income was $537.9 million (+422.3% year over year), for a net margin of 18.3% versus a median of 13.0% in the prior 5 years. Gross margin was 67.4% (up from 58.9%) and operating margin 16.3%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $2.94B | $2.52B | $1.57B | $1.02B | $958.10M |
| Growth | +16.65% | +60.62% | +53.34% | +6.76% | +21.43% |
| Net income | $537.87M | $102.98M | $122.87M | $190.17M | $149.19M |
| EPS (diluted) | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 |
Analyst forecast
ForecastConsensus (15 analysts)
buy
Avg. price target
$93.43+39.68%
- Strong buy 4
- Buy 6
- Hold 5
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 5, 2026
- EPS actual vs est.
- $1.04 vs $1.20
- Surprise
- -13.33%
GMED news
All GMED news- The Zacks Analyst Blog Highlights Hinge Health, OPKO Health, Globus Medical and Merit Medical SystemsNasdaqMMSI, OPK, GMED, HNGE
- MiniMed Launches MiniMed Flex Pump in Europe to Expand Diabetes Care (Revised)NasdaqMMED, MMSI, OPK, GMED
- HNGE Stock Surges Nearly 146% YTD: Can Its Growth Story Continue?NasdaqHNGE, MMSI, OPK, GMED
- MiniMed Launches MiniMed Flex Pump in Europe to Expand Diabetes CareNasdaqMMED, MMSI, OPK, GMED
- Globus Medical, Inc. (GMED) Presents at Jefferies Global Healthcare Conference 2026 TranscriptSeeking Alpha
- Should You Continue to Hold ALGN Stock in Your Portfolio?NasdaqALGN, IDXX, GMED, PAHC
- Here's Why You Should Retain NVST Stock in Your Portfolio for NowNasdaqNVST, IDXX, GMED, PAHC
- Should You Continue to Retain Bruker Stock in Your Portfolio?NasdaqBRKR, IDXX, GMED, PAHC
Globus Medical peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PODDInsulet Corporation | 133.17 | -2.96% | $9.24B | vs GMED |
| TFXTeleflex Incorporated | 161.58 | -1.11% | $6.41B | vs GMED |
| HAEHaemonetics Corporation | 120.16 | -0.17% | $5.47B | vs GMED |
| PENPenumbra Inc. | 319.12 | -0.28% | $12.58B | vs GMED |
| MMSIMerit Medical Systems Inc. | 84.34 | -0.08% | $5.05B | vs GMED |
| BAXBaxter International Inc. | 25.39 | 0.00% | $13.14B | vs GMED |
| MMEDMiniMed Group Inc. | 16.01 | -1.54% | $4.50B | vs GMED |
| ICUIICU Medical Inc. | 172.52 | -1.84% | $4.31B | vs GMED |
Indexes, lists and sector
Globus Medical stock FAQ
What is Globus Medical's stock price today?
GMED last traded at $66.89 as of Nov 20, 4:00 PM EST, down 2.49% on the day. Prices are delayed at least 15 minutes.
What is GMED's P/E ratio?
GMED trades at a trailing P/E ratio of 16.48 and a forward P/E of 12.53, compared with a median of 62.7 for its closest peers.
Who is Globus Medical's CEO?
Mr. Keith W. Pfeil is the chief executive officer of Globus Medical Inc. Class A, which has about 6,000 employees.
What is the GMED 52-week high?
The 52-week high for GMED is $101.40 and the 52-week low is $66.63. The stock is currently 34.0% below its high.